University of California San Francisco

Publications

  1. Correction: Evaluation of a pilot cancer patient navigation program in the limited-resource setting of Trinidad and Tobago.
    Badal K, Monroe N, Mohamed A, Maniam A, Badal M, Maharaj K
    J Cancer Educ. 2025 Feb; 40(1):110.; 
    PubMed
  2. Correction to: Evaluation of a pilot cancer patient navigation program in the limited‑resource setting of Trinidad and Tobago.
    Badal K, Monroe N, Mohamed A, Maniam A, Badal M, Maharaj K
    J Cancer Educ. 2025 Aug; 40(4):643.; 
    PubMed
  3. Results of Five Years of a Cancer Patient Navigation Training Program for Limited-Resource Settings in the Caribbean and Africa.
    Badal K, Monroe N, Mohamed A, Maniam A, Badal M, Maharaj K
    JCO Glob Oncol. 2025 Jun; 11:e2400535.; 
    PubMed
  4. WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design.
    Fiscalini A, Blum K, Fergus K, Hiatt RA, Naeim A, Kaster A, Scheuner MT, van 't Veer LJ, LaCroix AZ, Borowsky AD, Olopade OI, Park HL, Esserman J, Lancaster R, Heditsian D, Brain S, Lee V, Goodman DL, Ross KS, Wenger N, Parker BA, Madlensky L, Tice JA, Shieh Y, Ziv E, Arasu VA, Anton-Culver H, Kaplan CP, Rhoads KF, Badal K, Hogarth M, Petruse A, Soto IA, Leggat-Barr K, Goodman S, Atamer J, Ryu R, Adduci K, Matthews JB, Eklund M, Athena/WISDOM Network Collaborators and Advocate Partners, Sabacan LP, Esserman L
    NPJ Breast Cancer. 2026 May 24.; 
    PubMed
  5. A Cancer Patient Navigation Training Program for Limited-Resource Settings: Results from 5 Years of Training.
    Badal K, Monroe N, Mohamed A, Maniam A, Badal M, Maharaj K
    J Cancer Educ. 2025 Feb; 40(1):102-109.; 
    PubMed
  6. Translating risk-based breast cancer screening to limited-resource settings.
    Badal K, Maniam A, Otis SU, Esserman LJ
    BMC Glob Public Health. 2025 Jul 03; 3(1):59.; 
    PubMed
  7. National yearly cost of breast cancer screening in the USA and projected cost of advocated guidelines: a simulation study with life table modelling.
    Badal K, Staib J, Tice JA, Kim MO, Eklund M, Wilson L, Dacosta Byfield S, Catlett K, Maffey L, Soonavala R, Shieh Y, Esserman LJ
    BMJ Open. 2025 Feb 17; 15(2):e089428.; 
    PubMed
  8. WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and Design.
    Fiscalini A, Blum K, Fergus K, Hiatt RA, Naeim A, Kaster A, Scheuner MT, van 't Veer LJ, LaCroix AZ, Borowsky AD, Olopade OI, Park HL, Esserman J, Lancaster R, Heditsian D, Brain S, Lee V, Goodman DL, Ross KS, Wenger N, Parker BA, Madlensky L, Tice JA, Shieh Y, Ziv E, Arasu VA, Anton-Culver H, Kaplan CP, Rhoads KF, Badal K, Hogarth M, Petruse A, Soto IA, Leggat-Barr K, Goodman S, Atamer J, Ryu R, Adduci K, Matthews JB, Eklund M, Athena/WISDOM Network Collaborators and Advocate Partners, Sabacan LP, Esserman L
    Res Sq. 2025 Dec 15.; 
    PubMed
  9. Guiding principles for the responsible development of artificial intelligence tools for healthcare.
    Badal K, Lee CM, Esserman LJ
    Commun Med (Lond). 2023 Apr 01; 3(1):47.; 
    PubMed
  10. Predicting therapeutic clinical trial enrollment for adult patients with low- and high-grade glioma using supervised machine learning.
    Mehari M, Warrier G, Dada A, Kabir A, Haskell-Mendoza AP, Tripathy A, Jha R, Nieblas-Bedolla E, Jackson JD, Gonzalez AT, Reason EH, Flusche AM, Reihl S, Dalton T, Negussie M, Gonzales CN, Ambati VS, Desjardins A, Daniel AGS, Krishna S, Chang S, Porter A, Fecci PE, Hollon T, Chukwueke UN, Badal K, Molinaro AM, Hervey-Jumper SL
    Sci Adv. 2025 Jun 06; 11(23):eadt5708.; 
    PubMed